Physician groups report revenue per provider in every partner meeting and profit per provider in almost none, because profit per provider requires allocating support staff, occupancy, administration, and shared ancillary lines to the people who consume them — and the allocation is where the arguments live. The groups that do the work discover that the income-distribution plan has been quietly transferring money between partners for years, and that the plan everyone agreed to is not the plan the numbers describe.
How should profit per provider be calculated?
Revenue is the easy part, and still misunderstood. Collections by rendering provider from the practice management system, on an accrual basis by date of service with the group's allowance applied at each provider's payer mix — not charges, which overstate the high-charge specialists, and not cash by date of deposit, which rewards the provider whose payers happened to pay this month. Ancillary revenue — imaging, laboratory, infusion, procedures, retail — is attributed to the ordering or performing provider as the plan defines, and the definition is written down because it decides who gets credit for a line the group built together.
Direct costs follow the provider. The provider's compensation and benefits; the clinical support staff dedicated to them — medical assistant, nurse, scribe — at actual cost; their malpractice premium; their continuing education and licensing; and any specific equipment or supplies their practice consumes. A provider with two medical assistants and a scribe costs the group US$150,000 more a year to support than one with a shared assistant, and that difference belongs on their line.
Shared costs are allocated by driver, and the drivers are written down. Occupancy by exam-room hours or scheduled clinic sessions; front desk and scheduling by visit count; billing by claim count or by payer-mix-weighted claim count, since a provider whose payers require authorization consumes more billing labor per claim; administration and management by direct cost or by provider headcount; technology by user; marketing by new-patient share. The basis is defensible to the provider who receives it and does not change month to month — a group that allocates by revenue punishes its producers, and a group that allocates nothing has every provider profitable and the overhead unexplained.
The result, and what it usually shows. Contribution per provider before allocation, and profit per provider after it, monthly, with the twelve-month trend. The typical first reading in a twelve-provider group: two or three providers carry the margin; three or four are near zero after allocation; two or three are negative, usually because of support-staff intensity, low utilization, or a payer mix heavy in the group's weakest contracts; and the ancillary lines, when attributed, change the ranking of two providers materially.
How do compensation plans compare against profit per provider?
Equal share. Partners divide profit equally regardless of production; the model that founded most groups and the one most likely to be transferring money by the time the group has eight or more partners. Profit per provider shows the transfer explicitly — the partner at US$640,000 of profit after allocation and the partner at US$210,000 both receiving US$425,000 — and the conversation that follows is not about whether the transfer exists but about whether the group chooses it.
Pure productivity. Compensation as a share of collections or as a rate per work relative value unit, less direct costs and allocated overhead; the model that rewards production and penalizes the provider who takes the Medicaid panel, teaches the residents, or runs the quality program. It also makes every provider indifferent to the group's shared investments, because a shared ancillary line's cost lands on them and its revenue may not.
Work relative value units versus collections, as finance sees it. Work relative value units measure effort independent of payer — the provider who sees Medicaid patients is credited for the same work as the provider who sees commercial — which protects access and mission and removes payer mix from the compensation argument; collections measure what the group actually received, which keeps compensation tied to the money. Finance's position: pay on work relative value units if the group wants providers indifferent to payer mix and is prepared to manage payer mix centrally through intake and contracting; pay on collections if the group wants every provider managing their own payer mix and accepts the access consequences; and in either case, set the conversion rate — dollars per unit or percentage of collections — from the group's own profit per provider so the plan is funded by the economics rather than by hope.
The hybrid most groups arrive at. A base tied to a production expectation at the group's break-even; a productivity component above it on work relative value units or collections; a shared pool for the group's collective investments — ancillary lines, quality bonuses, panel management — distributed on defined criteria; and explicit, written stipends for the roles that production does not reward: medical director, quality lead, call coverage, teaching. The hybrid is not a compromise; it is the plan that prices each thing the group wants separately.
What hidden transfers does an equal-share plan make?
Support-staff intensity. Two providers with identical production and a US$150,000 difference in dedicated staff cost have a US$150,000 difference in profit; under equal share, one subsidizes the other without anyone having decided to.
Payer mix. A provider whose panel is 40 percent in the group's weakest contract produces the same visits at 20 percent less net revenue; under a collections-based plan they are penalized for a panel the group may have asked them to take; under equal share, the others are subsidizing a mission choice nobody wrote down.
Ancillary attribution. The provider who orders the imaging and the provider who built the imaging line are not the same person; a plan that attributes ancillary profit to ordering providers rewards referral behavior, and one that attributes it to the group pool rewards the investment — the choice is a policy, and most groups have made it by default.
Call, administration, and teaching. Unpaid roles are transfers from the people who do them to the people who do not; the hybrid prices them.
How should profit per provider be presented to the partners?
The numbers make the conversation possible; they do not make it easy. Profit per provider is presented to the partners together, by the finance function, with the allocation basis explained and defended — once, in detail — and then the group decides what it wants its plan to do: protect access, reward production, fund shared investments, pay for leadership. The plan is then designed to those goals and modeled for every partner's compensation before and after at current and expected production, with transition terms for the partners whose income would fall, because a plan change that loses a producing partner costs more than any inefficiency it fixed.
Governance after the change. The allocation bases documented and changed only at year-end; profit per provider in the monthly partner report; the plan reviewed annually against the market and the economics; and stipends and pool criteria revisited on a schedule rather than when someone complains.
Why is this CFO work?
The accrual revenue by provider with allowance at each provider's payer mix, the direct-cost attribution, the allocation design, the profit-per-provider report, the compensation-plan modeling across every partner, and the transition terms are finance work; the partners own the goals and the decision; the managing partner owns the conversation. The CFO's role is to make the transfers visible, model the alternatives honestly, and keep the allocation from becoming the argument.
Worked example
A twelve-provider multi-specialty group, US$14.6 million net revenue, equal-share partnership of nine partners plus three employed physicians, two ancillary lines (imaging and in-office laboratory).
| Provider (anonymized) | Net revenue | Direct cost | Contribution | Allocated shared cost | Profit after allocation | Equal-share distribution |
|---|---|---|---|---|---|---|
| Partner A (procedural specialty) | US$1,890,000 | US$830,000 | US$1,060,000 | US$390,000 | US$670,000 | US$425,000 |
| Partner B (primary care, Medicaid-heavy panel) | US$1,010,000 | US$560,000 | US$450,000 | US$290,000 | US$160,000 | US$425,000 |
| Partner C (two dedicated assistants + scribe) | US$1,420,000 | US$860,000 | US$560,000 | US$330,000 | US$230,000 | US$425,000 |
| Partner D (medical director, 0.3 admin) | US$1,120,000 | US$590,000 | US$530,000 | US$300,000 | US$230,000 | US$425,000 |
| Partners E–I (five) | US$6,310,000 | US$3,150,000 | US$3,160,000 | US$1,470,000 | US$1,690,000 (avg US$338,000) | US$425,000 each |
| Employed physicians (three) | US$2,850,000 | US$1,940,000 | US$910,000 | US$640,000 | US$270,000 | salaried |
| Imaging line (unattributed) | — | — | US$180,000 | US$110,000 | US$70,000 | pool |
| Laboratory line (unattributed) | — | — | US$95,000 | US$60,000 | US$35,000 | pool |
Illustrative figures for a hypothetical organization; not a client's data.
Partner A was transferring roughly US$245,000 a year to the partnership; Partner B was receiving US$265,000 more than their profit after allocation, on a panel the group had asked them to carry; Partner C's support-staff intensity cost the partnership US$150,000 a year without a decision; Partner D's medical-director time was unpaid and showed as low production. The hybrid adopted: a base at a production expectation set at break-even for each specialty; productivity above it on work relative value units at a conversion rate funded by the group's own economics; a shared pool from the ancillary lines and a quality fund, distributed on criteria that included panel access; written stipends for the medical director (US$60,000), quality lead, and call; and support-staff cost above a standard charged to the provider's line. Modeled before and after: seven partners' compensation rose or held, two fell — both received three-year transition guarantees; Partner B's panel was recognized through the access criteria in the pool and a Medicaid differential; Partner A stayed. No partner left in the following eighteen months.